US 12,404,306 B2
Human papillomavirus vaccines and uses of the same
Douglas E. Brough, Germantown, MD (US); Cheryl G. Bolinger, Germantown, MD (US); Ramya Yarlagadda, Blacksburg, VA (US); Vinodhbabu Kurella, Blacksburg, VA (US); Prabakaran Ponraj, Blacksburg, VA (US); Simon Metenou, Germantown, MD (US); and Kuan-Fu Ding, Blacksburg, VA (US)
Assigned to Precigen, Inc., Germantown, MD (US)
Appl. No. 16/978,573
Filed by Precigen, Inc., Germantown, MD (US)
PCT Filed Mar. 6, 2019, PCT No. PCT/US2019/020933
§ 371(c)(1), (2) Date Sep. 4, 2020,
PCT Pub. No. WO2019/173465, PCT Pub. Date Sep. 12, 2019.
Claims priority of provisional application 62/639,354, filed on Mar. 6, 2018.
Prior Publication US 2021/0024586 A1, Jan. 28, 2021
Int. Cl. C07K 14/005 (2006.01); A61K 39/12 (2006.01); A61K 39/29 (2006.01); A61K 48/00 (2006.01); C07K 14/02 (2006.01); C12N 7/00 (2006.01); C12N 15/861 (2006.01)
CPC C07K 14/005 (2013.01) [A61K 39/12 (2013.01); A61K 39/292 (2013.01); A61K 48/0066 (2013.01); C07K 14/02 (2013.01); C12N 7/00 (2013.01); C12N 15/861 (2013.01); C07K 2319/33 (2013.01); C12N 2710/20022 (2013.01); C12N 2710/20034 (2013.01)] 12 Claims
 
1. A polynucleotide encoding a polypeptide construct comprising the amino acid sequence of SEQ ID NO: 52 or 54.